|XGAMX -- USA Fund|| |
USD 44.14 0.02 0.0453%
Mr. Arthur G. Altschul, Jr. is Independent Director of General American Investors Company, Inc. In addition to his tenure since 1995 as a Director of the Company, Mr. Altschul is CoFounder and Chairman of Kolltan Pharmaceuticals, Inc. a founder and Managing Member of Diaz Altschul Capital Management, LLC and Chairman of Overbrook Management Corporationrationration . Mr. Altschul served as a Director from 1992 to December 2012 and was a member of the Audit Committee of Medicis Pharmaceutical Corporationrationration until it was acquired by and merged into Valeant Pharmaceuticals International in December 2012. From 1992 to 1996, Mr. Altschul worked at SUGEN, Inc. a biopharmaceutical firm. Prior to 1992, Mr. Altschul worked in the Equity and Fixed Income Trading departments at Goldman, Sachs Co. was a founding limited partner of The Maximus Fund, LP, and worked in the Equity Research department at Morgan Stanley Company. Mr. Altschul is a Director of Delta Opportunity Fund, Ltd., an investment fund which invests primarily in the health care industry. Mr. Altschul serves on the Board of Directors of Child Mind Institute and is a Trustee of the Neurosciences Research Foundation
Age: 51 Director Since 1995
Altschul holds a B.S. from Columbia University in Computer Science.